These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4825938)

  • 21. [The pseudoneurasthenic syndrome in the early stage of coronary arteriosclerosis].
    Polzien P; Walter J
    Munch Med Wochenschr; 1971 Oct; 113(44):1453-6. PubMed ID: 5171458
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical characteristics of neurasthenia in adolescents who suffered birth trauma].
    Bibik VA
    Vopr Okhr Materin Det; 1976 Dec; 21(12):60. PubMed ID: 1027270
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oxazepam in general practice].
    Schützler H
    Lakartidningen; 1968 Mar; 65(12):1190-1. PubMed ID: 5743135
    [No Abstract]   [Full Text] [Related]  

  • 24. [The differential use of trace element electrophoresis in neurasthenia].
    Kakuliia NA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (6):21-3. PubMed ID: 7762202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of the selective anxiolytic agent afobazol].
    Neznamov GG; Siuniakov SA; Chumakov DV; Bochkarev VK; Seredenin SB
    Eksp Klin Farmakol; 2001; 64(2):15-9. PubMed ID: 11548440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pseudoasthenic syndrome in the initial period of schizophrenia].
    Voskresenskiĭ VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(1):70-4. PubMed ID: 6702380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Catamnesis of asthenic developments in children].
    Buianov MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(10):1562-6. PubMed ID: 5709187
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ocular manifestations of botulism. Apropos of 3 cases].
    Laroche L; Ollat H; Mignot B; Claux JM; Saraux H
    Bull Soc Ophtalmol Fr; 1984 May; 84(5):555-8. PubMed ID: 6534583
    [No Abstract]   [Full Text] [Related]  

  • 29. [Transcranial micropolarisation in the treatment of adolescent neurasthenia].
    Chutko LS; Kropotov IuD; Surushkina SIu; Iakovenko EA; Nikishena IS; Anisimova TI; Livinskaia AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):34-5. PubMed ID: 16149418
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the level of disadaptation of higher nervous activity using electropolygram analysis].
    Frolov BS; Dutov VB; Puzyrevskiĭ AK; Iashchenko IuV
    Fiziol Cheloveka; 1985; 11(3):457-62. PubMed ID: 4054470
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of cardio-neurotic diseases in general practice: clinical experience with atarax].
    Smulevich AB; Syrkin AL; Drobizhev MIu; Ivanov SV; Lebedeva OI; Andreev AM
    Klin Med (Mosk); 1999; 77(1):43-6. PubMed ID: 10097506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frequency of morbidity caused by derangement of the central nervous system in watchmen].
    Rusu O
    Arch Mal Prof; 1966 Jun; 27(6):491-4. PubMed ID: 5936789
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinico-pathophysiologic characteristics of general sensation in patients with neurasthenia and hysterical neuroses].
    Shogam II; Rechitskiĭ IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1842-7. PubMed ID: 7340328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
    Pizzolato G; Cagnin A; Mancia D; Caffarra P; Avanzi S; Copelli S; Ciappina C; Lo Presti F; Spilimbergo PG; D'Antonio E; Di Costanzo E; Matrango M; Pastres P; Urbani PP; Signorino M; Simoncelli M; Provinciali L; Regnicolo L; Albano C; Roccatagliata G; Rubino V; Cultrera S; Fracassi M
    Arzneimittelforschung; 1997 Nov; 47(11A):1329-31. PubMed ID: 9450159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurasthenia-like syndrome: a modern therapeutic approach with a combined vitamin-mineral preparation].
    Caragliano A; Caragliano V; Riolo S
    Clin Ter; 1984 Feb; 108(3):209-13. PubMed ID: 6232058
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and psychometric observations on the therapeutic effect of an association of GABA-1-glutamine-aspartate-pyridoxal-phosphate in a group of psychoneurotic neurasthenic patients].
    Fabiani F; Martini P; Franceschi-Biagiotti F
    Riv Neurobiol; 1969; 15(1):35-62. PubMed ID: 5399614
    [No Abstract]   [Full Text] [Related]  

  • 37. [Application of aminazine electrophoresis in patients with neurasthenia and sleep disorders].
    Moshkin AP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1968; 33(5):460-1. PubMed ID: 5744035
    [No Abstract]   [Full Text] [Related]  

  • 38. [The dependence of the range of fusion on some selected functions of the visual system. Part II: Accommodation and dominance].
    Adamek B; Karczewicz D
    Klin Oczna; 2006; 108(4-6):167-9. PubMed ID: 17019986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of prazepam (mono demetrin) and bromazepam in general psychovegetative disorders. A controlled multicenter field study].
    Blaha L
    Fortschr Med; 1982 Nov; 100(44):2075-80. PubMed ID: 6129184
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of the bioelectrical activity of the brain during electric sleep therapy in patients with neurogenic functional disorders of the cardiovascular system].
    Andreva VM; Sorokina EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):516-22. PubMed ID: 5687862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.